Sign up to save your podcasts
Or
Share 100% Bullish: Simvastatin in MS, Communicating Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
100% Bullish: Simvastatin in MS, Communicating Risk
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
More shows like The Rounds Table
View all
This American Life
91,297 Listeners
Radiolab
43,837 Listeners
NEJM This Week
321 Listeners
Emergency Medicine Cases
549 Listeners
AFP: American Family Physician Podcast
701 Listeners
JAMA Clinical Reviews
504 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The Intern At Work: Internal Medicine
68 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Critical Care Scenarios
260 Listeners
The Cribsiders
320 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
What Now? with Trevor Noah
4,294 Listeners